GlassScriptPhysician profile
Ulku C Turba
NPI 1639228661
$5,704.92
in general payments reported to CMS, 2019-2025
13 companies · $266 in 2025
The $266 reported for 2025 was less than what a typical Vascular & Interventional Radiology provider received nationally (typical 2025 total: $537).
See the full distribution for Vascular & Interventional Radiology
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,915 · 2021: $215 · 2023: $85.14 · 2024: $223 · 2025: $266.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $575.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $574.83 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cardiovascular Systems INC. | $3,643.14 | 2019-2021 | |
| Bard Peripheral Vascular, INC. | $1,224.60 | 2019-2021 | |
| Inari Medical, INC. | $182.06 | 2024-2025 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Penumbra, INC. | $150.31 | 2025 | Indigo System |
| Cook Medical LLC | $149.44 | 2019-2025 | Torcon Nb, Zilver Vena, Tornado |
| Medtronic Vascular, INC. | $131.00 | 2019 | |
| Angiodynamics, INC. | $57.26 | 2021-2023 | Auryon Laser System 100-120 Vac |
| Medtronic, INC. | $48.30 | 2023-2025 | Concertotm, Abre |
| Boston Scientific Corporation | $45.02 | 2024 | Spyglass Discover |
| Covidien LP | $19.86 | 2019 | |
| Abbott Laboratories | $19.85 | 2019 | |
| Terumo Medical Corporation | $17.35 | 2019 | |
| Shockwave Medical, INC | $16.73 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ulku Turba listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.